India's 2023 contraction was widely reported as a funding winter. The more accurate description is a change in what gets funded — and the businesses that struggled were largely those whose models the market had already been questioning.
Indian venture funding fell substantially in 2023 from its 2021 peak. The contraction was widely described as a funding winter, which is accurate about the magnitude and misleading about the cause.
The contraction was primarily a withdrawal of foreign capital, and the reasons were largely external. As the 2021 report describes, a substantial share of the 2021 surge had come from capital reallocating within Asia and from the globally abundant conditions of that year. When those conditions reversed — rates rose, global venture contracted, and LP liquidity constrained commitment pacing — the capital that had arrived for reasons elsewhere left for reasons elsewhere.
Indian conditions had not deteriorated correspondingly. Growth continued, the domestic economy performed reasonably, and the structural case the 2023 Asia-Pacific report describes remained intact.
The distinction matters because it determines what recovers and when. A contraction caused by deteriorating local conditions recovers when those conditions improve. One caused by the withdrawal of foreign capital recovers when conditions elsewhere improve — which is outside anyone's local control.
The year's most durable development was the growth of domestic capital. Indian institutional investors, family offices and corporate investors became a larger share of funding. That reduces the sensitivity described above, and it is the single most important structural improvement in the market.
The businesses that struggled were largely predictable, and the 2017 report describes why. Models requiring high revenue per user, or funded by discounting, faced the test that abundance had deferred. The removal of subsidy capital did not create the problem; it brought forward the point at which it became visible.
What distinguished 2023 from previous Indian contractions was that the exit route stayed open. Domestic listing remained available, which meant companies with genuine businesses had a path.
Tracing the withdrawal precisely matters, because it determines what the contraction was actually measuring.
The 2021 surge had three components, per the 2021 report:
The first two reversed and the third did not.
Global abundance ended for the reasons the 2022 reports describe. Regional reallocation stabilised as the initial repositioning completed. Structural interest persisted, and Indian allocations remained above their pre-2021 levels.
The consequence is that the contraction from the 2021 peak overstates the deterioration, because the peak itself was inflated by two temporary components. The more informative comparison is against 2019 or 2020 rather than against 2021 — and on that comparison, Indian funding remained substantially higher.
The general point is one worth applying to any market that experienced a 2021 surge: measuring a contraction from a peak that was itself anomalous overstates it. The relevant baseline is the pre-surge trend, not the surge.
This is the same error, in the opposite direction, as the pull-forward mistake the 2020 US venture report describes — extrapolating from the steepest part of a curve. In both cases the error is choosing the anomalous period as the reference.
The growth of domestic capital is the year's most consequential development and deserves treatment on its own terms.
The sources that grew:
Why this matters more than the amount suggests:
The connection to the exit route matters and is worth making explicit. As the 2021 report describes, domestic listing brought Indian institutional investors into venture-backed companies as public shareholders. That familiarity supports their participation as private investors — the public and private markets develop together, and the exit route opening is part of what enabled the domestic capital growth.
For foreign investors the competitive implication is the one the 2025 Asia-Pacific report generalises: capital alone is no longer a differentiated offer. Participation increasingly requires something else — cross-border expertise, access to international markets, or specialist sector knowledge.
The businesses that struggled in 2023 were largely those the 2017 report identifies as structurally constrained, and the mechanism is worth stating because it is the clearest available illustration.
The 2017 analysis: models requiring high revenue per user face an arithmetic bound in a market where the addressable segment for that spending is small. Discount-funded growth measures price sensitivity rather than demand. Metrics measured under subsidy describe the subsidised state.
What capital abundance did: it allowed businesses to fund losses for longer, deferring the point at which the constraint became visible. A business burning capital to subsidise transactions can continue as long as capital is available.
What the contraction did: it removed the deferral. Businesses that could not raise had to reach profitability with what they had, which required ending subsidies, which revealed what the subsidies had been purchasing.
The results separated cleanly, as the 2017 report anticipates:
Capital abundance defers the test of a business model. It does not change the answer. The contraction did not create the problem — it removed the funding that had been concealing it.
The general observation, which recurs throughout this archive: a period of easy capital does not fix weak business models; it postpones the discovery. The 2019 US venture report describes the same pattern at the level of an entire market, and the 2023 US venture report describes the deferrals expiring globally.
India's bifurcation in 2023 ran along a different axis than the US's, and the difference is diagnostic in the sense the 2025 Asia-Pacific report describes.
In the US, the axis was artificial intelligence. Thematic exposure determined capital availability.
In India, the axis was profitability. Companies with demonstrated unit economics could raise; companies without could not, largely regardless of sector.
What that reveals: Indian capital in 2023 was selecting for capital efficiency rather than for thematic exposure. That is a market disciplined by an experience of subsidy-funded growth failing, underwriting to cash generation rather than to a future sale.
The consequences:
This is the healthier configuration, per the 2025 Asia-Pacific report's framework, and it is less exciting. A market that has learned to underwrite to profitability has learned something durable — and the learning came at the cost of the 2021 vintage.
The claim that measuring from the 2021 peak overstates the contraction is a general point about cyclical measurement, and it is worth setting out because the error is made routinely in both directions.
The problem. A measurement is a comparison, and a comparison requires a reference point. Choosing an anomalous period as the reference produces a result that describes the anomaly rather than the change.
The two symmetric errors:
The 2020 US venture report describes a third version of the same error: annualising from the steepest part of an adoption curve. In each case the mistake is selecting the least representative point as the reference.
How to choose a better baseline:
A contraction measured from an inflated peak is partly the deflation of the inflation. That is a real thing to describe and it is not the same as deterioration, and the two are routinely reported as one.
Attribute a contraction to its cause before drawing conclusions. A contraction caused by deteriorating local conditions recovers when those improve. One caused by foreign capital withdrawal recovers when conditions elsewhere improve — which is outside anyone's local control. The distinction determines what recovers and when, and the two look identical in funding totals.
Track domestic capital share as the stability indicator. Domestic capital has local liabilities and is less likely to withdraw during a global risk-off episode. SEBI publishes free quarterly data on alternative investment fund commitments, which distinguishes domestic activity from foreign flows in a way commercial providers do not.
Recognise that abundance defers a business model test rather than answering it. Businesses whose models required customers to spend more than the addressable segment could afford did not become viable through longer runway. The contraction did not create the problem — it removed the funding that had been concealing it, which is why the outcomes separated so cleanly.
Read the bifurcation axis as diagnostic. India bifurcated on profitability rather than on theme, which indicates a market underwriting to cash generation rather than to a future sale. That produces lower dispersion, more durable businesses, and lower and safer returns. It is the healthier configuration and it is less exciting, and it was learned at the cost of the 2021 vintage.
Note that the public and private markets developed together. Domestic listing brought Indian institutions into venture-backed companies as public shareholders, and that familiarity supported their participation as private investors. The exit route opening is part of what enabled the domestic capital growth, which means the two developments reinforce rather than merely coincide.
A structural retrospective on Indian venture capital in 2023, focused on what the contraction was actually measuring and what the year changed structurally.
Where figures appear they carry a numbered source. Mechanisms — capital source and contraction attribution, baseline selection in cyclical measurement, domestic capital stability, deferred business model tests, bifurcation axis as diagnostic — are analysis with reasoning shown.
This report follows the 2017 and 2021 India reports and is the country companion to the 2023 Asia-Pacific report.
India Venture Capital Report 2017 sets out the income arithmetic whose test this report describes arriving — why models requiring high revenue per user face an arithmetic bound, why any metric measured under subsidy describes the subsidised state, and why the addressable market is set by spending capacity rather than population.
India Venture Capital Report 2021 describes the surge this report measures the contraction from, including the three components of that surge — global abundance, regional reallocation and genuine structural interest — of which two reversed. It also describes the opening of the domestic listing route that kept this contraction from resembling previous ones.
India Venture Capital Outlook 2026 closes the sequence, separating the allocation question from the entry price question and scoring the whole four-part arc.
For the global context, the US Venture Capital Report 2023 describes the same year from the perspective of the market whose capital withdrawal drove India's contraction — the LP liquidity chain binding, deferrals expiring, and the measurement gap in downturn data.
For the regional context, the Asia-Pacific Investment Report 2023 describes institutions unbundling regional allocations, with India becoming a standalone position for many of them, and the 2025 regional report develops the bifurcation-axis framework this report applies.
On the deferred-test mechanism — that capital abundance postpones the discovery of a weak business model rather than changing the answer — the fullest treatments are the Global Investment Outlook 2019 on interrupted corrections and the US Venture Capital Report 2023 on deferrals expiring.
Accredited investors receive our market reports, private event invitations and curated deal flow.
.png)




